Existing literature demonstrates that i-tRF-Glu modulates the expression of glutamine synthetase (GLUL) and related enzymes governing Glu-to-Gln conversion, mechanistically linking this tRNA-derived fragment to the pro-metastatic metabolic reprogramming characteristic of colorectal cancer progression (63). The gene discussed is GLUL; the disease is colorectal cancer.